Goodwin, Latham Steer $2.8B Drug Discovery SPAC Deal
Boston-based drug discovery startup Valo Health LLC said Wednesday that it plans to go public at a valuation of about $2.8 billion through a merger with a blank check company, in...To view the full article, register now.
Already a subscriber? Click here to view full article